InterCure Ltd.
INCR · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $281 | $294 | $254 | $327 |
| - Cash | $51 | $51 | $78 | $79 |
| + Debt | $179 | $179 | $211 | $211 |
| Enterprise Value | $409 | $422 | $387 | $460 |
| Revenue | $65 | $65 | $57 | $57 |
| % Growth | 0% | 14.9% | 0% | – |
| Gross Profit | $20 | $20 | $0 | $0 |
| % Margin | 30.9% | 30.9% | 0.3% | 0.3% |
| EBITDA | $7 | $7 | -$47 | -$47 |
| % Margin | 11% | 11% | -82.5% | -83.2% |
| Net Income | -$1 | -$1 | -$35 | -$35 |
| % Margin | -1.3% | -1.3% | -61.2% | -61.2% |
| EPS Diluted | -0.015 | -0.015 | -0.79 | -0.79 |
| % Growth | 0% | 98.1% | 0% | – |
| Operating Cash Flow | $6 | $6 | $0 | $0 |
| Capital Expenditures | -$2 | -$2 | $0 | $0 |
| Free Cash Flow | $4 | $4 | $0 | $0 |